Cincinnati Children’s® Installs EOS imaging System

Regulatory News:

EOS Imaging (Paris:EOSI) (NYSE Euronext, FR0011191766 – EOSI), the pioneer in orthopaedic 2D/3D imaging, today announced the installation of the EOS imaging system at Cincinnati Children’s Hospital Medical Center. This EOS System installation underscores Cincinnati Children’s® commitment to safe pediatric radiological imaging. EOS will be incorporated into regular clinical practice to obtain full-body, weight-bearing 2D/3D scans and enable improved diagnosis of musculoskeletal conditions.

Cincinnati Children’s Hospital Medical Center ranked third of all U.S. children’s hospitals by two entities – the 2013-14 list of Best Children’s Hospitals published by U.S. News & World Report and Parents magazine’s 10 Best Children’s Hospitals survey. Cincinnati Children’s also ranked among the top three hospitals for all of the six areas of pediatric subspecialty care surveyed, including second in the nation for orthopaedic care. Cincinnati Children’s is also a founding member of The Alliance for Radiation Safety’s Image Gently campaign. The goal of the Alliance, and Image Gently, is to improve unsafe imaging practice by raising awareness of opportunities to lower radiation dose in the imaging of children.

The EOS system provides full-body images of patients in a natural standing or seated position in both 2D and 3D with 50% to 85% less dose than Digital Radiology and 95% than basic CT scans in accordance with the ALARA (As Low As Reasonably Achievable) principle of radiation reduction. For these reasons, the EOS system is the ideal mode of imaging for monitoring the treatment of pediatric scoliosis patients.

Marie Meynadier, CEO of EOS imaging, said, "We are always proud to work with partners in the radiology community that focus on reducing radiation exposure in diagnosis, treatment planning and monitoring. Since our inception, EOS has been a pioneer in leading the way to safer radiographic imaging thanks to our proprietary detection technology. We are pleased that leading orthopaedic and radiology departments like Cincinnati Children’s recognize our efforts and adopt the EOS system as the standard of care in responsible pediatric imaging.”

For further information about the Company or EOS®, the first full body, low dose 2D/3D imaging system, please visit http://www.eos-imaging.com/.

About EOS imaging:
EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Company is authorized to market the system in 32 countries, including the United States (FDA), Japan, Canada, Australia and the European Union (EU). Backed by an installed base of 75 sites and more than 400,000 imaging sessions, EOS® benefits from worldwide recognition within the global medical community. As of December 31, 2013 the Group posted 2013 consolidated revenue of €15.2 million and employed 101 people including an R&D team of 38 engineers. The Group is based in Paris and holds four subsidiaries in Besançon (France), Cambridge (Massachusetts), in Montreal (Canada) and Frankfurt (Germany), and offices in Singapore. For further information, please visit www.eos-imaging.com

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

Next press release: revenue for the 1^st half of 2014, on July 22, 2014 (after market).